Abstract
High toxicity of anticancer drugs led to development of targeted drug delivery directly to the specific organs. Polyamine transport system (PTS) of mammalian cells is one of the targets for a cell-selective drug delivery of polyamine–drug conjugates into specific organs. Even without having a 3D structure for mammalian PTS, synthesis of polyamine derivatives and evaluation of their cytotoxic effects are potential practical approaches to find optimal polyamine moieties to be transported from the PTSs. Chinese hamster ovary (CHO) and its mutant cell line (CHO-MG) are two important cells for evaluation of polyamine transportation by polyamine transporters (PAT). If a polyamine conjugate ligand demonstrates a high IC50 ratio on CHO-MG/CHO cells, this indicates a high selectivity of such compound toward PAT. This study discussed the structural requirements (charge, linker, vector, cargo) of polyamine conjugates in order to be transported into the cells by the mean of PTS.
Similar content being viewed by others
References
Gerner EW, Meyskens Jr FL (2004) Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4(10):781
Cohen SS (1998) Guide to the polyamines, 1st edn. Oxford University Press, London
Marton LJ, Pegg AE (1995) Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35(1):55–91
TABOR H, Tabor CW (1964) Spermidine, spermine, and related amines. Pharmacol Rev 16(3):245–300
Bachrach U (2010) The early history of polyamine research. Plant Physiol Biochem 48(7):490–495
Sakai TT, Torget R, Freda CE, Cohen SS (1975) The binding of polyamines and of ethidium bromide to tRNA. Nucleic Acids Res 2(7):1005–1022
Feuerstein BG, Williams LD, Basu HS, Marton LJ (1991) Implications and concepts of polyamine-nucleic acid interactions. J Cell Biochem 46(1):37–47
Wang J-Y, Casero RA (2006) Polyamine cell signaling: physiology, pharmacology, and cancer research, 1st edn. Springer-Verlag New York, LLC
Ha HC, Sirisoma NS, Kuppusamy P, Zweier JL, Woster PM, Casero RA (1998) The natural polyamine spermine functions directly as a free radical scavenger. Proc Natl Acad Sci 95(19):11140–11145
Kurata HT, Marton LJ, Nichols CG (2006) The polyamine binding site in inward rectifier K+ channels. J Gen Physiol 127(5):467–480
Poulin R, Casero R, Soulet D (2012) Recent advances in the molecular biology of metazoan polyamine transport. Amino Acids 42(2–3):711–723
Shantz LM (2004) Transcriptional and translational control of ornithine decarboxylase during Ras transformation. Biochem J 377(1):257–264
Pegg AE (2006) Regulation of ornithine decarboxylase. J Biol Chem 281(21):14529–14532
Nowotarski SL, Shantz LM (2010) Cytoplasmic accumulation of the RNA-binding protein HuR stabilizes the ornithine decarboxylase transcript in a murine nonmelanoma skin cancer model. J Biol Chem 285(41):31885–31894
Ikeguchi Y, Bewley MC, Pegg AE (2006) Aminopropyltransferases: function, structure and genetics. J Biochem 139(1):1–9
Korhonen V-P, Halmekytö M, Kauppinen L, Myöhänen S, Wahlfors J, Keinänen T, Hyvönen T, Alhonen L, Eloranta T, Jänne J (1995) Molecular cloning of a cDNA encoding human spermine synthase. DNA Cell Biol 14(10):841–847
Wahlfors J, Alhonen L, Kauppinen L, Hyvönen T, Jänne J, Eloranta TO (1990) Human spermidine synthase: cloning and primary structure. DNA Cell Biol 9(2):103–110
Casero RA, Pegg AE (1993) Spermidine/spermine N1-acetyltransferase—the turning point in polyamine metabolism. FASEB J 7(8):653–661
Casero RA, Pegg AE (2009) Polyamine catabolism and disease. Biochem J 421(3):323–338
Xie X, Gillies RJ, Gerner EW (1997) Characterization of a diamine exporter in Chinese hamster ovary cells and identification of specific polyamine substrates. J Biol Chem 272(33):20484–20489
Vujcic S, Liang P, Diegelman P, Kramer DL, Porter CW (2003) Genomic identification and biochemical characterization of the mammalian polyamine oxidase involved in polyamine back-conversion. Biochem J 370(1):19–28
Wu T, Yankovskaya V, McIntire WS (2003) Cloning, sequencing, and heterologous expression of the murine peroxisomal flavoprotein, N1-acetylated polyamine oxidase. J Biol Chem 278(23):20514–20525
Soulet D, Gagnon B, Rivest S, Audette M, Poulin R (2004) A fluorescent probe of polyamine transport accumulates into intracellular acidic vesicles via a two-step mechanism. J Biol Chem 279(47):49355–49366
Belting M, Persson S, Fransson L-Å (1999) Proteoglycan involvement in polyamine uptake. Biochem J 338(2):317–323
Belting M, Mani K, Jönsson M, Cheng F, Sandgren S, Jonsson S, Ding K, Delcros J-G, Fransson L-Å (2003) Glypican-1 is a vehicle for polyamine uptake in mammalian cells a pivotal role for nitrosothiol-derived nitric oxide. J Biol Chem 278(47):47181–47189
Wallace HM, Fraser AV, Hughes A (2003) A perspective of polyamine metabolism. Biochem J 376(1):1–14
Palmer AJ, Wallace HM (2010) The polyamine transport system as a target for anticancer drug development. Amino Acids 38(2):415–422
Byers TL, Pegg AE (1989) Properties and physiological function of the polyamine transport system. Am J Phys Cell Phys 257(3):C545–C553
Delcros J-G, Tomasi S, Carrington S, Martin B, Renault J, Blagbrough IS, Uriac P (2002) Effect of spermine conjugation on the cytotoxicity and cellular transport of acridine. J Med Chem 45(23):5098–5111
Mandel JL, Flintoff WF (1978) Isolation of mutant mammalian cells altered in polyamine transport. J Cell Physiol 97(3):335–343
Corcé V, Renaud SP, Cannie I, Julienne K, Gouin SG, Loréal O, Gaboriau F, Deniaud D (2014) Synthesis and biological properties of Quilamines II, new iron chelators with antiproliferative activities. Bioconjug Chem 25(2):320–334
Bergeron RJ, McManis JS, Weimar WR, Schreier K, Gao F, Wu Q, Ortiz-Ocasio J, Luchetta GR, Porter C, Vinson JT (1995) The role of charge in polyamine analog recognition. J Med Chem 38(13):2278–2285
Bergeron RJ, McManis JS, Liu CZ, Feng Y, Weimar WR, Luchetta GR, Wu Q, Ortiz-Ocasio J, Vinson JT (1994) Antiproliferative properties of polyamine analogs: a structure-activity study. J Med Chem 37(21):3464–3476
Bergeron RJ, Neims AH, McManis JS, Hawthorne TR, Vinson JR, Bortell R, Ingeno MJ (1988) Synthetic polyamine analogs as antineoplastics. J Med Chem 31(6):1183–1190
Bergeron RJ, McManis JS, Franklin AM, Yao H, Weimar WR (2003) Polyamine–Iron chelator conjugate. J Med Chem 46(25):5478–5483
Nick H, Acklin P, Lattmann R, Buehlmayer P, Hauffe S, Schupp J, Alberti D (2003) Development of tridentate iron chelators: from desferrithiocin to ICL670. Curr Med Chem 10(12):1065–1076
Bergeron RJ, Singh S, Bharti N, Jiang Y (2010) Design, synthesis, and testing of polyamine vectored iron chelators. Synthesis 2010(21):3631–3636
Bergeron RJ, Bharti N, Wiegand J, McManis JS, Yao H, Prokai L (2005) Polyamine-vectored iron chelators: the role of charge. J Med Chem 48(12):4120–4137
Wang C, Delcros J-G, Biggerstaff J, Phanstiel IV O (2003) Molecular requirements for targeting the polyamine transport system. Synthesis and biological evaluation of polyamine–anthracene conjugates. J Med Chem 46(13):2672–2682
Wang C, Delcros J-G, Biggerstaff J, Phanstiel IV O (2003) Synthesis and biological evaluation of N-(anthracen-9-ylmethyl)triamines as molecular recognition elements for the polyamine transporter. J Med Chem 46(13):2663–2671
Gardner RA, Delcros J-G, Konate F, Breitbeil F, Martin B, Sigman M, Huang M, Phanstiel IV O (2004) N-substituent effects in the selective delivery of polyamine conjugates into cells containing active polyamine transporters. J Med Chem 47(24):6055–6069
Padariya M, Kalathiya U, Baginski M (2015) Structural and dynamic changes adopted by EmrE, multidrug transporter protein—studies by molecular dynamics simulation. Biochim Biophys Acta Biomembr 1848(10):2065–2074
Breitbeil III F, Kaur N, Delcros J-G, Martin B, Abboud KA, Phanstiel IV O (2006) Modeling the preferred shapes of polyamine transporter ligands and dihydromotuporamine-C mimics: shovel versus hoe. J Med Chem 49(8):2407–2416
Wang C, Delcros J-G, Cannon L, Konate F, Carias H, Biggerstaff J, Gardner RA, Phanstiel IV O (2003) Defining the molecular requirements for the selective delivery of polyamine conjugates into cells containing active polyamine transporters. J Med Chem 46(24):5129–5138
Kaur N, Delcros J-G, Imran J, Khaled A, Chehtane M, Tschammer N, Martin B, Phanstiel Iv O (2008) A comparison of chloroambucil- and xylene-containing polyamines leads to improved ligands for accessing the polyamine transport system. J Med Chem 51(5):1393–1401
Kaur N, Delcros J-G, Archer J, Weagraff NZ, Martin B, Phanstiel Iv O (2008) Designing the polyamine pharmacophore: influence of N-substituents on the transport behavior of polyamine conjugates. J Med Chem 51(8):2551–2560
Muth A, Kamel J, Kaur N, Shicora AC, Ayene IS, Gilmour SK, Phanstiel IV O (2013) Development of polyamine transport ligands with improved metabolic stability and selectivity against specific human cancers. J Med Chem 56(14):5819–5828
Phanstiel O, Kaur N, Delcros J-G (2007) Structure-activity investigations of polyamine-anthracene conjugates and their uptake via the polyamine transporter. Amino Acids 33(2):305–313
Corcé V, Morin E, Guihéneuf S, Renault E, Renaud S, Cannie I, Tripier R, Lima LM, Julienne K, Gouin SG (2012) Polyaminoquinoline iron chelators for vectorization of antiproliferative agents: design, synthesis, and validation. Bioconjug Chem 23(9):1952–1968
Kaur N, Delcros J-G, Martin B, Phanstiel IV O (2005) Synthesis and biological evaluation of dihydromotuporamine derivatives in cells containing active polyamine transporters. J Med Chem 48(11):3832–3839
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Mohamad Reza Nazifi, S., Sadeghi-aliabadi, H., Fassihi, A. et al. Structure–activity relationship of polyamine conjugates for uptake via polyamine transport system. Struct Chem 30, 175–184 (2019). https://doi.org/10.1007/s11224-018-1175-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11224-018-1175-4